Dutch Health Minister Hugo de Jonge has announced that the country could prepare three more booster vaccinations against the coronavirus.
De Jonge wrote a letter to his country’s parliament on Wednesday suggesting that the Netherlands should consider additional booster vaccinations to combat new variants, two in 2022 and one more in 2023.
The letter also states that the Netherlands has enough booster vaccines for the current booster campaign.
In the letter, De Jonge wrote: “Since a booster dose of Moderna only takes half a regular vaccine, we now have enough vaccines for the current booster campaign and there is a sufficient base for possible additional booster rounds in the second quarter and autumn 2022 and 2023.
The Netherlands bought vaccine stocks in large quantities to avoid shortages.
The country has ordered nearly 6 million additional vaccines on top of the 12 million already purchased from Pfizer / Biontech.
There is already an agreement with Pfizer / Biontech for at least another 17.5 million doses by 2023. It is unclear who will be eligible for these coronavirus booster vaccinations in 2022 and 2023.
Pfizer / Biontech is working on a vaccine that is adapted to the current Omicron variant.
Pfizer / Biontech has stated that it will take them at least 100 days to develop, approve and ramp up production of a modified vaccine. Delivery is expected in April at the earliest.
On December 29, those born in 1983 and 1984 were requested to have a booster vaccination by the city health department. The following day, those born in 1985 and 1986 were told they could schedule their vaccinations.
The latest data on the vaccination rate in the country can also be found on the website of the Dutch government.
By December 26, 89 percent of people over the age of 18 had received at least one dose of vaccine. A total of 85.9 percent of 18-year-olds and older are fully vaccinated.
Only 20 percent of those over 18 are fully vaccinated and have received a booster, but not all age groups are currently able to make an appointment for the booster. See source for more details.
Switzerland also seems to be planning further “booster vaccinations”.
So far, the federal government has signed contracts with five vaccine manufacturers: Moderna (13.5 million vaccine doses for 2021 and 7 million for 2022), Pfizer / BioNTech (around 6 million vaccine doses), AstraZeneca (around 5.3 million vaccine doses), Curevac ( 5 million vaccine doses) and Novavax (6 million). The vaccines from Moderna and BioNTech / Pfizer are currently in use in the cantons; Approvals for further Covid-19 vaccines are still pending. Obtaining vaccines from different manufacturers is intended to ensure that sufficient doses of an approved vaccine are available even in the event of delivery difficulties. Those